5AM Venture Management, LLC

Q2 2025 13F Holdings

  • Location
    san francisco, CA
  • Num holdings

    29

  • Value ($000)

    $260,120

  • Date Filed
    08/14/2025
  • Form type
    13F-HR
  • CIK
    0001799883
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
SKYE
SKYE

SKYE BIOSCIENCE INC

COM NEW
83086J200
$41.44M
16 %

9,913,168

TRDA
TRDA

ENTRADA THERAPEUTICS INC

COM
29384C108
$28.95M
11 %

4,308,379

DNTH
DNTH

DIANTHUS THERAPEUTICS INC

COM
252828108
$18.35M
7 %

984,725

ELVN
ELVN

ENLIVEN THERAPEUTICS INC

COM
29337E102
$15.50M
6 %

772,477

---

PHARVARIS N V

COM
N69605108
$14.04M
5 %

797,600

MLTX
MLTX

MOONLAKE IMMUNOTHERAPEUTICS

CLASS A ORD
61559X104
$13.33M
5 %

282,313

CNTA
CNTA

CENTESSA PHARMACEUTICALS PLC

SPONSORED ADS
152309100
$10.92M
4 %

830,945

VOR
VOR

VOR BIOPHARMA INC

COM
929033108
$10.31M
4 %

6,361,723

VRDN
VRDN

VIRIDIAN THERAPEUTICS INC

COM
92790C104
$10.30M
4 %

736,595

TECX
TECX

TECTONIC THERAPEUTIC INC

COM
878972108
$10.17M
4 %

511,660

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 29